Search Results (287)

In recent years, yeast glucan particles (YGPs) have garnered significant attention as novel oral drug delivery carriers, owing to their superior biocompatibility, specific targeting capabilities, and intrinsic immunomodulatory properties. The yeast cell wall is primarily composed of β-glucan and mannan, with minor amounts of proteins and lipids. Among these, β-1,3-glucan serves as the pivotal functional component. It not only provides a physical barrier protecting payloads from gastric acidity and enzymatic degradation but also functions as a targeting ligand. By specifically binding to M cells in Peyer’s patches and Dectin-1 receptors on macrophages and dendritic cells, β-1,3-glucan facilitates precise drug delivery to gut-associated lymphoid tissue (GALT) or macrophage-rich inflammatory sites. Consequently, β-1,3-glucan-based YGPs demonstrate immense potential in oral targeted delivery systems for macrophage-associated pathologies. However, native YGPs, constrained by their inherent porous architecture and relatively simple physicochemical properties, often fall short of meeting the complex requirements for precise encapsulation, controlled release, and multifunctionality. To address these limitations, current research is actively exploring the functionalization of YGPs with various composite materials to engineer advanced delivery platforms. This review introduces the composition, structural characteristics, and fabrication methodologies of YGPs, alongside their specific merits and limitations in oral drug delivery. Furthermore, it critically analyzes strategies for modifying YGPs with composite materials to overcome delivery barriers. Finally, the review discusses their therapeutic applications across various diseases and outlines future developmental trends. Full article

Saponins, the primary bioactive constituents with immunomodulatory activities in Baoyuan decoction—a traditional Chinese medicine formula composed of ginseng, astragalus, licorice, and cinnamon—are limited by low extraction yield, poor stability, and easy degradation. In this study, cellulase and pectinase were used for the extraction of saponins from Baoyuan decoction and optimized by response surface methodology. Subsequently, the optimal extracts were microencapsulated by spray drying with soy protein isolate (SPI) or high-oleic acid soy protein isolate (HOSPI) and pectin (PE) as composite wall materials, followed by application evaluation in gummies and in vitro digestion. After optimization, the total saponin yield was 63.68 ± 0.15 mg/g. HOSPI-PE microcapsules (HBP) had a higher encapsulation efficiency (90.38%), smaller particle size, and lower hygroscopicity than SPI-PE ones (SBP). Furthermore, both microcapsules showed good stability during storage and controlled release, with 60.9% of saponins in SBP and 65.8% in HBP being delivered to the intestinal phase during in vitro digestion of microparticles. When applied in gummies, microcapsule gummies retained satisfactory sustained-release in vitro digestion (23.0% released in the stomach and 66.2% in the small intestine). In contrast, the unencapsulated gummies exhibited a burst release (74.4%) at 30 min in gastric digestion. This study provides theoretical and technical insights into the development of plant-derived functional foods and promotes the practical application of microencapsulation in functional gummy candies. Full article

Bamboo is widely available and renewable. Using bamboo blocks to partially replace coarse aggregates in the production of concrete solid bricks shows promising application prospects in areas such as nonload-bearing wall materials. However, as a natural biomass material, bamboo squares have disadvantages such as susceptibility to decay, water absorption, swelling, and drying shrinkage, necessitating modification when used as concrete coarse aggregate. This study subjected raw bamboo squares to high-temperature carbonization. The compressive performance of concrete made with these carbonized bamboo squares was first tested and compared with concrete containing raw bamboo squares. Subsequently, both raw and carbonized bamboo squares were modified using conventional methods: polyvinyl alcohol (PVA) treatment, epoxy mortar (EM) treatment, epoxy resin (EPR) treatment, water glass (WG) treatment, and glutinous rice glue treatment. Modified bamboo block concrete specimens were prepared, and their compressive strengths were tested and compared. The results indicated that the compressive mechanical performance of carbonized bamboo block concrete consistently outperformed that of raw bamboo block concrete across all substitution rates. Specifically, the optimal modification method—using epoxy mortar (EM) encapsulation—significantly enhanced the mechanical properties. At a high volumetric replacement rate of 30%, the EM-modified carbonized bamboo concrete achieved a compressive strength of 27.79 MPa, which is 15.1% higher than that of identically treated raw bamboo concrete and far exceeds the standard MU7.5 grade requirements. These quantitative findings provide a solid experimental and theoretical basis for the high-value application of bamboo squares in sustainable concrete solid bricks. Full article

The microencapsulation of plant bioactive compounds by spray drying enhances their stability and controlled delivery in food systems. In this study, flaxseed hydrocolloid (Linum usitatissimum L.) was evaluated as a natural wall material for encapsulating phenolic extracts from mashua (Tropaeolum tuberosum Ruiz & Pav.) and oca (Oxalis tuberosa Molina). Microcapsules were produced using hydrocolloid concentrations of 2.5–10%. The resulting particles showed low moisture content (3.79–5.42%), low water activity (0.31–0.39), and high solubility (90.94–96.45%). Encapsulation efficiency ranged from 78.67 to 62.32% for mashua and from 71.94 to 40.45% for oca, decreasing with increasing wall material concentration. Phenolic content ranged from 14.48 to 11.47 mg GAE/g (mashua) and 8.52 to 4.82 mg GAE/g (oca), with antioxidant capacity between 293.19–143.77 and 84.49–10.33 µmol TE/g, respectively. Particle size ranged from 4.02–10.50 µm (mashua) and 3.93–4.82 µm (oca), and zeta potential values (−37.86 to −27.55 mV) indicated good colloidal stability. Release kinetics showed a biphasic profile and were predominantly diffusion-controlled. The Higuchi model showed significant diffusion (p < 0.05), while the Korsmeyer–Peppas analysis indicated mainly Fickian diffusion (n = 0.234–0.426) with anomalous transport at higher mashua concentrations. These results demonstrate that flaxseed hydrocolloid is an effective and sustainable wall material for controlled release of phenolic compounds from Andean tubers. Full article

This study investigated the characteristics and bioactive properties of olive oils obtained from regional Nizip Yaglik (NY) and Kilis Yaglik (KY) olive varieties, encapsulated using maltodextrin (MD) and whey protein isolate (WPI) as wall materials. Olive oils were first emulsified with different WPI–MD ratios (1:1, 1:4, 1:10) and subsequently freeze-dried to produce microcapsule powders. A comprehensive evaluation was conducted, including physicochemical properties (encapsulation efficiency, moisture content, water activity, bulk density, flowability, wettability, particle size, and color), FTIR spectral profiles, morphological features, total phenolic content, and antioxidant activity. The results demonstrated that combining WPI with MD yielded high encapsulation efficiency and favorable reconstitution characteristics, effectively protecting sensitive bioactive constituents from oxidative degradation during processing and storage. Increasing the proportion of MD in the wall matrix improved emulsion stability and microencapsulation yield, while also slightly enhancing powder brightness. FTIR analyses confirmed that the fundamental chemical structure of olive oil was preserved across all formulations. The freeze-dried microcapsules displayed superior stability relative to non-encapsulated oils, retaining higher levels of phenolic compounds and antioxidant capacity. Among the formulations, elevated MD ratios enhanced powder flowability, whereas WPI played a crucial role in emulsification performance and capsule surface integrity. Overall, these findings underscore the effectiveness of MD–WPI blends as promising wall materials for the freeze-drying encapsulation of regional olive oils, offering a viable strategy to preserve their distinctive qualities and bioactive potential for functional food applications. Full article

Bacteriophages (phages) offer a targeted biocontrol solution, but their direct application is hampered by environmental instability. To address this, we developed a novel, food-grade microcapsule system for phage delivery using layer-by-layer (LbL) self-assembly of zein and carboxymethyl chitosan (CMCS). Lytic phages targeting specific spoilage bacteria were successfully encapsulated via electrostatic interactions. Characterization confirmed the formation of a multilayer structure, driven primarily by hydrogen bonding and electrostatic forces between the wall materials. The microencapsulation markedly enhanced phage stability against thermal (60 °C and 70 °C) and extreme pH (2.0, 12.0) stresses and provided a controlled release profile in a simulated fish exudate. When applied to fresh-cut sea bass (Lateolabrax japonicus), the phage-loaded microcapsules (CMCS3), constructed via a three-layer zein/CMCS LbL assembly, significantly delayed the pH rise during refrigerated storage, maintaining a final pH of 6.28 compared to 7.28 in the control group after 5 days. The microcapsules also effectively suppressed microbial growth (total viable count (TVC) was maintained below 6 log CFU/g) and controlled lipid oxidation (thiobarbituric acid reactive substances (TBARS) values were kept at 0.62 mg malondialdehyde/kg) while better preserving texture and color stability compared to free phages. This zein/CMCS-based LbL system presents a promising strategy for advancing phage-based biopreservation in aquatic products through enhanced physical protection, sustained release, and improved stress tolerance. Full article

This study aimed to develop a pH-responsive microencapsulation system using complex coacervation with chitosan (CS) and hydrolyzed karaya gum (HKG) as natural wall materials to encapsulate ginger essential oil (GEO) as a core material. Key parameters influencing coacervate formation and encapsulation efficiency were studied and optimized. The results indicated that the maximum complexation yield (77.3%) was achieved at a pH of 4.6 with a CS:HKG mass ratio of 1:2. Under these optimal conditions, microcapsules were fabricated at various wall-to-core ratios, with the 3:1 ratio demonstrating the highest encapsulation efficiency (65.73%) and process yield (75.7%). Physicochemical characterization revealed that the microcapsules possessed low hygroscopicity and a pH-dependent solubility profile. Scanning electron microscopy (SEM) showed that freeze-dried microcapsules had a more porous, amorphous structure compared to the denser, irregular particles produced by oven-drying. Crucially, in vitro release studies demonstrated a pronounced pH-responsive behavior: GEO release was significantly faster and more extensive in simulated gastric fluid (pH 2.0) than in neutral or simulated intestinal fluid (pH 7.4). These findings highlight the successful fabrication of a stable CS-HKG micro-delivery system that effectively protects GEO and facilitates its controlled, targeted release in acidic environments, indicating strong potential for applications in gastric targeted functional food and pharmaceutical products. Full article

Rosemary essential oil (REO) is a complex mixture of volatile organic compounds (VOCs), predominantly oxygenated monoterpenes such as 1,8-cineole, camphor, and borneol, which together exhibit antioxidant and antimicrobial activities. These properties make REO a promising natural alternative to synthetic food additives; however, its high volatility, low water solubility, chemical instability, and intense aroma significantly limit its direct application in food systems. Encapsulation has therefore emerged as a key strategy to enhance REO stability, preserve bioactivity, and enable controlled release while reducing sensory impact. This review critically examines conventional and advanced techniques for REO encapsulation. These techniques are comparatively evaluated by addressing their advantages and limitations, with particular emphasis on wall material selection and its role in controlling release behaviour and functional performance in real food matrices. In addition to summarising current applications in food preservation, functional ingredients, and active packaging, this review highlights a key research gap: the limited post-encapsulation characterisation of REO chemical composition, especially minor VOCs responsible for synergistic biological effects. Addressing this gap is essential for the design of encapsulation systems that effectively integrate aroma, preservation, and functionality in clean-label food products. Full article

The objective of this study was to explore the effect of the assembly sequences of wall materials on the structure and properties of Antarctic krill peptide (AKP)-loaded ovalbumin (OVA)–chitosan (CS) nanoparticles (NPs). Two AKP-loaded NPs (CS/OVA-AKP and OVA/CS-AKP) were prepared by changing the sequences of OVA and CS. The results confirmed that CS/OVA-AKP had a smaller particle size (291 nm vs. 320 nm), lower polydispersity index (0.233 vs. 0.282), higher absolute zeta potential (34.4 mV vs. 32.1 mV), and higher encapsulation efficiency (81.6% vs. 75.4%) than OVA/CS-AKP. X-ray diffraction analysis confirmed that AKP was encapsulated in an amorphous state within the NPs. Fourier transform infrared spectroscopy and three-dimensional (3D) fluorescence spectroscopy revealed that electrostatic interactions, hydrogen bonding, and hydrophobic interactions were the primary driving forces for nanoparticle formation, with CS/OVA-AKP demonstrating a stronger OVA fluorescence quenching effect. Compared with OVA/CS-AKP, CS/OVA-AKP exhibited better redispersibility, and CS/OVA-AKP showed greater stability under various environmental factors (thermal treatment, salt concentration, pH, and storage time). During simulated gastrointestinal digestion, CS/OVA-AKP effectively protected AKP from gastric degradation and showed a higher AKP release rate in simulated intestinal fluid (61.1%) than OVA/CS-AKP (53.0%). The release followed the Korsmeyer–Peppas model, with OVA/CS-AKP exhibiting non-Fickian diffusion (n = 0.7500), and CS/OVA-AKP approached Case II transport (n = 0.9889), indicating erosion-controlled release behavior. CS/OVA-AKP also demonstrated higher hypoglycemic activity, with inhibition rates of 41.1%, 37.5%, and 36.1% for α-glucosidase, α-amylase, and DPP-IV, respectively. These findings underscore the important influence of wall-material assembly sequences on the structure and properties of AKP-loaded NPs, offering valuable insights for the development of bioactive peptide delivery systems. Full article

Cinnamaldehyde (CIN) is a natural organic compound known for its antimicrobial and antioxidant properties. However, its susceptibility to environmental degradation has restricted its practical application. This study aimed to microencapsulate CIN using soy protein isolate hydrolysates and maltodextrin as wall materials through emulsion preparation and spray drying, and to characterize the microstructure, controlled-release properties, antibacterial efficacy, and preservation performance of the resulting microcapsules. Under optimized condition, the encapsulation efficiency reached 70.72%. The microcapsules displayed smooth spherical structures, improved thermal stability, and an average particle size of 291.01 ± 33.64 nm. They demonstrated enhanced storage stability and sustained-release characteristics. Furthermore, the microcapsules exhibited significant antibacterial and antioxidant activity, which effectively delayed lipid and protein oxidation in pork loin for up to 6 days. Collectively, the results confirm the successful encapsulation of CIN and indicate the strong potential of these microcapsules for food industry applications requiring preservative and controlled-release functions. Full article

In response to thermal failure risks in ultra-high voltage (UHV) bushing online monitoring devices and maintenance equipment—caused by high heat generation of electronic components and the intrinsically low thermal conductivity of conventional resin encapsulation materials—this study proposes a novel modification strategy based on flash Joule heating (FJH). Distinct from conventional interface modification methods, the proposed approach enables cross-scale, in situ microsoldering between multi-walled carbon nanotubes (MWCNTs) and carbon fibers (CFs), constructing a multiscale reinforcement network with integrated thermal transport and mechanical load transfer pathways. The transient ultra-high-temperature thermal shock generated by FJH not only effectively removes inert impurities on CF surfaces but also drives carbon structural reconstruction, enabling graphitic-level welding of MWCNTs onto the fiber surface. This micro-welded architecture fundamentally differs from traditional filler dispersion or interface coating strategies, which often suffer from the trade-off between interfacial thermal transport and mechanical bonding. By contrast, the FJH-induced carbon–carbon bonded nodes form a continuous conductive and load-bearing network at the micro–nano scale. Characterizations using scanning electron microscopy (SEM), Raman spectroscopy, and X-ray photoelectron spectroscopy (XPS) confirm successful in situ welding of MWCNTs onto CF surfaces. Meanwhile, FJH treatment effectively removes oxygen-containing functional groups and surface impurities. Analysis of carbon bonding evolution indicates that the welding efficiency reaches its maximum at 90 V. Macroscopic performance tests demonstrate that, compared with epoxy resin, the thermal conductivity of the multiscale reinforced system increases by approximately 168%, while the mechanical strength improves by 62.72%. This study provides new theoretical insights and technical pathways for the development of next-generation polymer composite materials with both high thermal conductivity and high mechanical strength. Full article

Implant science has traditionally treated “biocompatibility” as the master criterion of success, focusing on cytotoxicity, corrosion, immune response, infection control, and the chemical stability of materials in vivo. However, many clinically “biocompatible” devices still fail at the point where the body actually meets the device: the mechanical interface. The interface is not a passive boundary. It is a living, adapting, mechanosensitive microenvironment in which cells integrate stiffness, micromotion, surface roughness, fluid shear, and wear debris with biochemical signals to decide whether to incorporate an implant, wall it off, resorb adjacent tissue, or trigger chronic inflammation. In load-bearing orthopaedics, stiffness mismatch produces stress shielding and maladaptive remodelling; excessive micromotion drives fibrous encapsulation rather than osseointegration; abrasive wear creates particulates that sustain macrophage activation and osteolysis; and design choices that are mechanically adequate in bench tests can still fail in vivo when the implant–tissue system evolves. In soft-tissue implantation, substrate stiffness can be a primary driver of the foreign body response and fibrotic capsule formation through mechanosensitive pathways, such as TRPV4-mediated macrophage–fibroblast signalling. Mechanical compatibility is not a replacement for classical biocompatibility; rather, it should be treated as a co-equal, first-class design requirement in mechanosensitive organisms. Chemically biocompatible materials can still fail through stiffness mismatch, micromotion, fretting and wear debris generation, and mechanobiology-driven fibrosis or osteolysis. We therefore propose a process view of implant success: tissue mechanics should be measured in clinically relevant states, transformed into constitutive models and interface performance envelopes, translated into explicit mechanical-compatibility specifications, and then realised through manufacturing process windows that can reliably reproduce targeted architectures and surface states. Additive manufacturing and microstructural engineering enable the tuning of modulus, the formation of porosity gradients, and the generation of patient-specific compliance fields, but these advances only improve outcomes when coupled to metrology, statistical process control, and validation loops that close the gap between intended and realised interface mechanics through clinical surveillance. Full article

Essential oils are natural insect repellents, which can be microencapsulated and protected by wall materials to provide prolonged protection against insects. The protection and release of these repellents depend on various parameters, including morphology and production conditions. Herein, twenty-seven gum arabic/citronella essential oil (GA/CEO) spray-dried microcapsules were produced by using three wall-to-core ratios (3:1, 4:1, 6:1), three inlet temperatures (120, 150, 180 °C), and three feed rates (1, 2.5, 5 mL/min). The morphology, particle size, encapsulation efficiency, and release rates were evaluated. The insect repellent activity of microcapsules (0.25, 0.5, and 1 g) against Drosophila melanogaster flies was tested. A systematic process optimization was carried out by evaluating the effects of both emulsion concentration and process parameters on the release rates. Microcapsules with smooth surfaces and homogeneous particle sizes were produced. Encapsulation efficiency reached 90% by increasing the inlet temperature and feed rate. Slower release rates (approximately 40%) were achieved with higher concentrations of the wall material and temperatures, generally. Optimal process conditions were determined as a wall-to-core ratio of 4:1, temperatures exceeding 150 °C, and feed rates above 2.5 mL/min. The highest repellent activity achieved was 95%, indicating effectiveness of GA/CEO microcapsules as insect repellent materials. Full article

The global shift toward antibiotic-free poultry production has created an urgent need for sustainable feed additives that promote gut health and productivity. This study aimed to develop and evaluate a novel double-layered microencapsulated phytosynbiotic (DMP) comprising Tiliacora triandra extract, probiotics, and cereal by-products using lyophilization. In Experiment 1, we investigated the effects of cell wall materials (corn, defatted rice bran, and wheat bran) and different particle sizes (0.6 and 1.0 mm) on the physicochemical characteristics and probiotic encapsulation efficiency. Results revealed that wheat bran, particularly at the smaller particle size of 0.6 mm, enhanced probiotic viability, probiotic stability under simulated gastrointestinal and thermal conditions, and nutrient retention. Compared with other materials, wheat bran also provided superior powder flowability, lower density, and favorable color attributes. In Experiment 2, we assessed the influence of probiotic strains (P. acidilactici, Lactiplantibacillus plantarum TISTR 926, and Streptococcus thermophilus TISTR 894) on functional properties of the DMP. All strains exhibited high encapsulation efficiency and stability during gastrointestinal simulation, thermal exposure, and storage. However, P. acidilactici had superior fermentation kinetics and produced greater levels of beneficial short-chain fatty acids, especially acetic and butyric acids. Antibacterial activity was strain-dependent, with notable inhibitory effects against Gram-positive pathogens, primarily through bacteriostatic mechanisms. Overall, these findings confirm that the developed DMP formulations effectively stabilize probiotics and bioactive phytochemicals, offering a promising strategy for enhancing gut health and performance in antibiotic-free broiler production systems. Full article

Systemic anticancer therapy causes a number of side effects; therefore, local drug release devices may play an important role in this area. In this study, we developed polyurethane-dendrimer foams containing different amounts of third-generation poly (amidoamine) dendrimers (PAMAM G3) to evaluate their ability to encapsulate and release the model anticancer drug doxorubicin (DOX), as well as their biocompatibility and effectiveness against normal and cancer cells in vitro. PU–PAMAM foams containing 10–50 wt% PAMAM G3 were prepared using glycerin-based polyether polyol and castor oil as co-components. Structural and rheological analyses revealed that foams containing up to 20 wt% PAMAM G3 exhibited a well-developed porous structure, while higher dendrimer loadings (≥30 wt%) led to irregular cell shapes, pore coalescence, and thinning of cell walls, and indicated a gradual loss of structural integrity. Rheological creep–recovery measurements confirmed the structural findings: moderate PAMAM G3 incorporation (≤20 wt%) increased both the instantaneous and delayed elastic modulus (E₁ ≈ 130–140 kPa; E₂ ≈ 80 kPa) and enhanced elastic recovery, reflecting improved cross-link density and foam stability. Higher dendrimer contents (30–50 wt%) caused a decline in these parameters and higher viscoelastic compliance, indicating a softer, less stable structure. The DOX loading capacity and encapsulation efficiency increased with PAMAM G3 content, reaching maximum values of 35% and 51% for 30–40 wt% PAMAM G3, respectively. However, the most sustained DOX release profiles were observed for matrices containing 20 wt% PAMAM G3. Analysis of cumulative release and kinetic modeling revealed a transition from diffusion-controlled release at low PAMAM contents to burst-dominated release at higher dendrimer loadings. Importantly, matrices containing 10–20 wt% PAMAM G3 also indicated selective anticancer action against squamous cell carcinoma (SCC-15) compared to non-cancerous human keratinocytes (HaCaT). Moreover, the DOX they released effectively destroyed cancer cells. Overall, PU–PAMAM foams containing 10–20 wt% PAMAM G3 provide the most balanced combination of structural stability, controlled drug release, and cytocompatibility. These materials therefore represent a promising platform as passive carriers in drug delivery systems (DDSs), such as local implants, anticancer patches, or bioactive wound dressings. Full article